You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 64950-0374


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 64950-0374

Drug Name NDC Price/Unit ($) Unit Date
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 64950-0374-16 0.42555 ML 2025-04-23
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 64950-0374-16 0.42223 ML 2025-03-19
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 64950-0374-16 0.41550 ML 2025-02-19
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 64950-0374-16 0.40387 ML 2025-01-22
ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION 64950-0374-16 0.39439 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 64950-0374

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 64950-0374

Introduction

The pharmaceutical industry is a complex and dynamic market, influenced by various factors including regulatory changes, technological advancements, and economic trends. When analyzing the market and price projections for a specific drug, such as the one identified by the National Drug Code (NDC) 64950-0374, it is crucial to consider these factors.

Understanding the NDC System

The NDC system, managed by the FDA, provides a unique identifier for each drug product. This code helps in tracking, pricing, and reimbursement of drugs. The NDC 64950-0374 would be associated with a specific drug product, including its strength, dosage form, and manufacturer[5].

Market Trends in the Pharmaceutical Industry

Pricing and Access

Pricing and access to drugs are significant concerns for the life sciences industry. C-suite executives often cite these as major issues that will impact their strategies in the coming years. Nearly half of the executives surveyed expect pricing and access to have a significant impact on their strategies in 2025[3].

Competition from Generics and Biosimilars

Competition from generic drugs and biosimilars is another key trend. With many high-revenue products facing patent expirations, the market is likely to see increased competition from generics and biosimilars. This could affect the pricing and market share of branded drugs[3].

Digital Transformation and Innovation

The integration of technologies like genomics, biomarkers, and artificial intelligence (AI) is expected to drive innovation and operational efficiencies in the pharmaceutical industry. These advancements can lead to more precise treatment options and better patient outcomes, which may influence market demand and pricing[3].

Price Projections

General Trends

Drug price inflation is projected to be around 3.81% for 2025, driven by high-cost therapies and expanding indications. This general trend can serve as a baseline for understanding potential price movements for specific drugs[4].

Specific Drug Pricing

To accurately project the price of a drug with the NDC 64950-0374, one would need to consider several factors:

  • Current Pricing: The current price of the drug, which can be obtained from databases like the FDA's National Drug Code Directory or pharmacy pricing lists.
  • Market Dynamics: The presence of competitors, including generics and biosimilars, can significantly impact pricing.
  • Regulatory Changes: Any changes in regulatory policies or FDA approvals can affect the drug's market position and pricing.
  • Demand and Supply: Changes in demand due to new indications or supply chain disruptions can also influence prices.

Regulatory Considerations

FDA Approvals and Withdrawals

Drugs must have FDA-approved applications to be included in programs like the Medicaid Drug Rebate Program. Any drug without an approved application, or one that has been subject to a voluntary withdrawal notice, would face significant market and pricing challenges[1].

NDC Directory Updates

The FDA's NDC Directory is crucial for tracking the marketing status of drugs. Any updates or changes in the marketing status of a drug, such as delisting or changes in the marketing start or end dates, can impact its pricing and availability[5].

Case Studies and Examples

Impact of Patent Expirations

The biopharma industry is facing a substantial loss of exclusivity due to expiring patents, with over $300 billion in sales at risk through 2030. This can lead to increased competition from generics and biosimilars, affecting the pricing of branded drugs[3].

Voluntary Withdrawals

The voluntary withdrawal of drugs like Meridia (sibutramine) and Darvon/Darvocet (propoxyphene) due to safety concerns highlights how regulatory actions can immediately impact a drug's market presence and pricing[1].

Key Takeaways

  • Pricing and Access: These remain significant challenges for the pharmaceutical industry.
  • Competition: Generics and biosimilars are increasingly competitive, especially with patent expirations.
  • Innovation: Digital transformation and scientific innovations are driving new treatment options and operational efficiencies.
  • Regulatory Impact: FDA approvals, withdrawals, and changes in the NDC Directory can significantly affect a drug's market position and pricing.
  • Market Dynamics: Demand, supply, and the presence of competitors are crucial factors in price projections.

FAQs

Q: What is the significance of the NDC system in the pharmaceutical industry? A: The NDC system provides a unique identifier for each drug product, facilitating tracking, pricing, and reimbursement.

Q: How do patent expirations affect drug pricing? A: Patent expirations lead to increased competition from generics and biosimilars, which can reduce the market share and pricing of branded drugs.

Q: What role does digital transformation play in the pharmaceutical industry? A: Digital transformation, including the use of genomics, biomarkers, and AI, drives innovation, operational efficiencies, and more precise treatment options.

Q: How do regulatory changes impact drug pricing? A: Regulatory changes, such as FDA approvals or withdrawals, can immediately affect a drug's market presence and pricing.

Q: What are the general trends in drug price inflation for 2025? A: Drug price inflation is projected to be around 3.81% for 2025, driven by high-cost therapies and expanding indications.

Sources

  1. Medicaid.gov: For State Technical Contacts - Medicaid[1]
  2. Missouri Department of Social Services: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023[2]
  3. Deloitte Insights: 2025 life sciences outlook[3]
  4. DrugPatentWatch: Latest drug prices and trends for NDC 00641-1398[4]
  5. FDA: National Drug Code Directory[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.